Multimodal Clinical Trial Platform
Thryve’s white-label research app supports the secure collection of digital biomarkers, patient-reported outcomes (PROs), and continuous physiological data from participants’ own devices.
Designed for Research Use Cases
Thryve's Features for World-Class Research and Trials
Power your research through:
API-first Architecture
Plug Thryve into your research backend or DTx platform.
Customizable UX
Deploy white-label versions or integrate Pulsatio as a module into your own app.
Sensor-Agnostic Design
Capture data from consumer and clinical-grade wearables.
Regulatory-Ready
Designed to support CE, MDR, and FDA documentation processes for evidence generation.
Infrastructure That Meets the Demands of Modern Clinical Studies
Launching your study with Thryve’s Multimodal Clinical Trial Platform is fast, secure, and fully supported. Whether you’re running a pilot or scaling to thousands of participants, we make setup seamless.
health trackers
health metrics
Accelerated trial setup & reduced operational burden
We help you launch studies in days, not months. With built-in onboarding flows, PRO modules, and SDK/API options, research teams can deploy without heavy internal development or IT dependencies.
Cross-device comparability (500+ data sources supported)
Collect standardized data across 500+ wearables and sensors. Thryve harmonizes metrics like heart rate, sleep, and activity across brands and models, ensuring comparability across participant cohorts and study phases.
Clinical-quality, fully traceable data flows
All data is securely encrypted, timestamped, and linked to device and user pseudonyms. This guarantees auditability, data provenance, and end-to-end traceability, meeting the expectations of both sponsors and regulators.
Support for EMA/FDA submissions
Designed with regulatory-grade compliance in mind, Thryve supports structured documentation, consistent data exports, and integration into CE, MDR, EMA, or FDA pathways. The platform is fully compliant and audit-ready, meeting GDPR, HIPAA, and ISO 27001/27018 standards to ensure secure, regulator-approved study execution.
Robust infrastructure for multi-country, multi-device trials
Run decentralized studies at scale across borders with multi-language support, secure cloud hosting, and device compatibility tailored to local markets. Thryve ensures your research can scale globally, without sacrificing compliance or participant experience.
Frequently Asked Questions:
- Who is the Multimodal Clinical Trial Platform built for?
- Thryve’s platform is designed for research teams, CROs, and digital health providers conducting clinical studies, post-market surveillance, or digital biomarker research. It supports both regulated and exploratory use cases.
- What kind of data can be collected?
- The platform captures data from over 500 wearables and medical devices (e.g. heart rate, activity, sleep, SpO₂) and supports patient-reported outcomes (PROs) via customizable in-app surveys.
- How is participant privacy protected?
- Participants use a pseudonym and PIN, ensuring data is pseudonymized at all times. Thryve does not collect personal identifiers and follows GDPR, HIPAA, and ISO standards for data security and ethical compliance.
- Can I use Thryve in regulated clinical studies?
- Yes. Thryve is suitable for use in CE, MDR, or FDA-submitted studies. The infrastructure is audit-ready, supports secure consent workflows, and enables digital endpoint validation and documentation.
- Is the Pulsatio app customizable?
- Yes. Pulsatio is available as a native app (iOS/Android) and can be deployed under your own brand or integrated into existing digital study environments.
- How long does integration take?
- Standard implementation can be completed within a few days. For custom workflows or white-labeled deployments, most teams launch within 2–4 weeks.
.png)
